Compound ID | 1203
Class: Pyridone
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against drug resistant Neisseria gonorrhoeae |
| Propensity to select resistant mutants: | Y (same order as ciprofloxacin) |
| Description: | Narasimhan. J., Peddi. S., Letinski. S., Jung. S., Wang. J., Gerasyuto. A., Arnold. M., Hedrick. J., Dumble. M., Karp. G., Branstorm. A."Mode of Action of Novel Fused 2-Pyridones Against Neisseria gonorrhoeae " Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy. 2015. |
| Institute where first reported: | Hsiri Therapeutics |
| Year first mentioned: | 2015 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |